Skip to main content
Premium Trial:

Request an Annual Quote

GPC, ICOS Strike Antibody Agreement

NEW YORK, Nov. 26 — GPC Biotech has signed an agreement to allow ICOS Corporation to develop and manufacture its anti-MHC class II antibody products, GPC said on Monday.

 

Terms of the arrangement call for ICOS, of Bothell, Wash., to conduct large-scale production of the two antibodies through a non-exclusive license to its mammalian cell-expression technology. GPC Biotech will retain rights to develop and commercialize the product.

Financial details of the deal were not disclosed.

 

GPC Biotech, a genomics and proteomics company based in Martinsried/Munich, Germany, identified these therapeutic antibody products with affinity for the MHC class II target through a research partnership with MorphoSys, also based in Martinsried/Munich.

 

One product is being developed as a potential treatment for certain types of B-cell lymphoma and the other may be an effective therapy for suppressing T-cell responses in the treatment of transplant rejection and graft-versus-host disease, GPC said. The antibodies were generated from MorphoSys' combinatorial antibody library.

 

Two weeks ago, GPC Biotech said that two new alliances have helped boost its third-quarter revenues by 65 percent to 3.5 million euros, or roughly $3.1 million, from 2.1 million euros in the year-ago period.

 

During the first nine months of the year, the company reported a 58 percent increase in research and development expenses to 23.4 million euros. GPC said that expenses from such activities totalled 14.8 million euros in the third quarter but did not offer a figure for the corresponding period in 2000.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.